Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Immuno-oncology Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Merck
Autolus Therapeutics
Takeda
GlaxoSmithKline
BioNTech SE
Arcus Biosciences
Janssen Biotech
Novartis
Roche
Allogene Therapeutics
Amgen
Spectrum Pharmaceuticals
Pfizer
IMAB-I-Mab Biopharma Co, Ltd
Gritstone Oncology
Sanofi
Bristol-Myers Squibb
By Type:
Immune System Modulators
Monoclonal Antibodies
Cancer Vaccines
Immune Checkpoint Inhibitors
By Application:
Others
Ambulatory Surgical Center
Hospitals
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Immuno-oncology Therapy Market Overview 2018-2029
-
1.1 China Immuno-oncology Therapy Industry Development Overview
-
1.2 China Immuno-oncology Therapy Industry Development History
-
1.3 China Immuno-oncology Therapy Industry Market Size (2018-2029)
-
1.4 China Immuno-oncology Therapy Market Analysis by Type from Production Side
-
1.4.1 China Immuno-oncology Therapy Production Volume, Production Value and Growth Rate of Immune System Modulators (2018-2029)
-
1.4.2 China Immuno-oncology Therapy Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.4.3 China Immuno-oncology Therapy Production Volume, Production Value and Growth Rate of Cancer Vaccines (2018-2029)
-
1.4.4 China Immuno-oncology Therapy Production Volume, Production Value and Growth Rate of Immune Checkpoint Inhibitors (2018-2029)
-
1.5 China Immuno-oncology Therapy Market Analysis by Application from Consumption End
-
1.5.1 China Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.2 China Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Center (2018-2029)
-
1.5.3 China Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.6 China Immuno-oncology Therapy Market Analysis by Region
-
1.6.1 North China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Immuno-oncology Therapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Immuno-oncology Therapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Immuno-oncology Therapy Market Status and Competition Analysis in 2023
-
2.2.3 China Immuno-oncology Therapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Immuno-oncology Therapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Immuno-oncology Therapy Industry Development
Chapter 3 Immuno-oncology TherapyIndustry Chain Analysis
-
3.1 Immuno-oncology Therapy Industry Chain
-
3.2 Immuno-oncology Therapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Immuno-oncology Therapy Market
-
3.3 Immuno-oncology Therapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Immuno-oncology Therapy Market
Chapter 4 China Immuno-oncology Therapy Market, by Type
-
4.1 China Immuno-oncology Therapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Immuno-oncology Therapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Immuno-oncology Therapy Production Volume and Growth Rate, by Type
-
4.5.1 China Immuno-oncology Therapy Production Volume and Growth Rate of Immune System Modulators
-
4.5.2 China Immuno-oncology Therapy Production Volume and Growth Rate of Monoclonal Antibodies
-
4.5.3 China Immuno-oncology Therapy Production Volume and Growth Rate of Cancer Vaccines
-
4.5.4 China Immuno-oncology Therapy Production Volume and Growth Rate of Immune Checkpoint Inhibitors
Chapter 5 China Immuno-oncology Therapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Immuno-oncology Therapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Immuno-oncology Therapy Market Size and Growth Rate, by Application
-
5.5.1 China Immuno-oncology Therapy Market Size and Growth Rate of Others
-
5.5.2 China Immuno-oncology Therapy Market Size and Growth Rate of Ambulatory Surgical Center
-
5.5.3 China Immuno-oncology Therapy Market Size and Growth Rate of Hospitals
Chapter 6 China Immuno-oncology Therapy Market, by Region
-
6.1 China Immuno-oncology Therapy Production Volume and Production Value, by Region
-
6.2 China Immuno-oncology Therapy Sales Volume and Sales Value, by Region
Chapter 7 North China Immuno-oncology Therapy Market Analysis
-
7.1 North China Immuno-oncology Therapy Market, by Type
-
7.2 North China Immuno-oncology Therapy Market, by Application
Chapter 8 Central China Immuno-oncology Therapy Market Analysis
-
8.1 Central China Immuno-oncology Therapy Market, by Type
-
8.2 Central China Immuno-oncology Therapy Market, by Application
Chapter 9 South China Immuno-oncology Therapy Market Analysis
-
9.1 South China Immuno-oncology Therapy Market, by Type
-
9.2 South China Immuno-oncology Therapy Market, by Application
Chapter 10 East China Immuno-oncology Therapy Market Analysis
-
10.1 East China Immuno-oncology Therapy Market, by Type
-
10.2 East China Immuno-oncology Therapy Market, by Application
Chapter 11 Northeast China Immuno-oncology Therapy Market Analysis
-
11.1 Northeast China Immuno-oncology Therapy Market, by Type
-
11.2 Northeast China Immuno-oncology Therapy Market, by Application
Chapter 12 Southwest China Immuno-oncology Therapy Market Analysis
-
12.1 Southwest China Immuno-oncology Therapy Market, by Type
-
12.2 Southwest China Immuno-oncology Therapy Market, by Application
Chapter 13 Northwest China Immuno-oncology Therapy Market Analysis
-
13.1 Northwest China Immuno-oncology Therapy Market, by Type
-
13.2 Northwest China Immuno-oncology Therapy Market, by Application
Chapter 14 Company Profiles
-
14.1 Merck
-
14.1.1 Merck Company Profile
-
14.1.2 Merck Immuno-oncology Therapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Autolus Therapeutics
-
14.2.1 Autolus Therapeutics Company Profile
-
14.2.2 Autolus Therapeutics Immuno-oncology Therapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Takeda
-
14.3.1 Takeda Company Profile
-
14.3.2 Takeda Immuno-oncology Therapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Profile
-
14.4.2 GlaxoSmithKline Immuno-oncology Therapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 BioNTech SE
-
14.5.1 BioNTech SE Company Profile
-
14.5.2 BioNTech SE Immuno-oncology Therapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Arcus Biosciences
-
14.6.1 Arcus Biosciences Company Profile
-
14.6.2 Arcus Biosciences Immuno-oncology Therapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Janssen Biotech
-
14.7.1 Janssen Biotech Company Profile
-
14.7.2 Janssen Biotech Immuno-oncology Therapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Novartis
-
14.8.1 Novartis Company Profile
-
14.8.2 Novartis Immuno-oncology Therapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Roche
-
14.9.1 Roche Company Profile
-
14.9.2 Roche Immuno-oncology Therapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Allogene Therapeutics
-
14.10.1 Allogene Therapeutics Company Profile
-
14.10.2 Allogene Therapeutics Immuno-oncology Therapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Amgen
-
14.11.1 Amgen Company Profile
-
14.11.2 Amgen Immuno-oncology Therapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Spectrum Pharmaceuticals
-
14.12.1 Spectrum Pharmaceuticals Company Profile
-
14.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Pfizer
-
14.13.1 Pfizer Company Profile
-
14.13.2 Pfizer Immuno-oncology Therapy Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 IMAB-I-Mab Biopharma Co, Ltd
-
14.14.1 IMAB-I-Mab Biopharma Co, Ltd Company Profile
-
14.14.2 IMAB-I-Mab Biopharma Co, Ltd Immuno-oncology Therapy Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Gritstone Oncology
-
14.15.1 Gritstone Oncology Company Profile
-
14.15.2 Gritstone Oncology Immuno-oncology Therapy Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Sanofi
-
14.16.1 Sanofi Company Profile
-
14.16.2 Sanofi Immuno-oncology Therapy Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Bristol-Myers Squibb
-
14.17.1 Bristol-Myers Squibb Company Profile
-
14.17.2 Bristol-Myers Squibb Immuno-oncology Therapy Market Performance
-
14.17.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Immuno-oncology Therapy Industry Research Conclusions
-
15.2 Immuno-oncology Therapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Immuno-oncology Therapy Industry Market Size (2018-2029)
-
Figure China Immuno-oncology Therapy Production Volume, Production Value and Growth Rate of Immune System Modulators (2018-2029)
-
Figure China Immuno-oncology Therapy Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure China Immuno-oncology Therapy Production Volume, Production Value and Growth Rate of Cancer Vaccines (2018-2029)
-
Figure China Immuno-oncology Therapy Production Volume, Production Value and Growth Rate of Immune Checkpoint Inhibitors (2018-2029)
-
Figure China Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Center (2018-2029)
-
Figure China Immuno-oncology Therapy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure North China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
Figure South China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
Figure East China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Immuno-oncology Therapy Market Size and Growth Rate from 2018-2029
-
Figure Immuno-oncology Therapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Immuno-oncology Therapy Market Share by Type in 2018
-
Figure China Immuno-oncology Therapy Market Share by Type in 2023
-
Figure China Immuno-oncology Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Immuno-oncology Therapy Production Volume and Growth Rate of Immune System Modulators (2018-2023)
-
Figure China Immuno-oncology Therapy Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Figure China Immuno-oncology Therapy Production Volume and Growth Rate of Cancer Vaccines (2018-2023)
-
Figure China Immuno-oncology Therapy Production Volume and Growth Rate of Immune Checkpoint Inhibitors (2018-2023)
-
Figure China Immuno-oncology Therapy Market Share by Application in 2018
-
Figure China Immuno-oncology Therapy Market Share by Application in 2023
-
Figure China Immuno-oncology Therapy Total Market Size and Growth Rate from Consumption End
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Others (2018-2023)
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Ambulatory Surgical Center (2018-2023)
-
Figure China Immuno-oncology Therapy Market Size and Growth Rate of Hospitals (2018-2023)
-
Table China Immuno-oncology Therapy Production Volume by Region (2018-2023)
-
Table China Immuno-oncology Therapy Production Volume Share by Region (2018-2023)
-
Figure China Immuno-oncology Therapy Production Volume Share by Region (2018-2023)
-
Table China Immuno-oncology Therapy Production Value by Region (2018-2023)
-
Table China Immuno-oncology Therapy Production Value Share by Region (2018-2023)
-
Figure China Immuno-oncology Therapy Production Value Share by Region (2018-2023)
-
Table China Immuno-oncology Therapy Sales Volume by Region (2018-2023)
-
Table China Immuno-oncology Therapy Sales Volume Share by Region (2018-2023)
-
Figure China Immuno-oncology Therapy Sales Volume Share by Region (2018-2023)
-
Table China Immuno-oncology Therapy Sales Value by Region (2018-2023)
-
Table China Immuno-oncology Therapy Sales Value Share by Region (2018-2023)
-
Figure China Immuno-oncology Therapy Sales Value Share by Region (2018-2023)
-
Table North China Immuno-oncology Therapy Production Volume by Type (2018-2023)
-
Table North China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Figure North China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Table North China Immuno-oncology Therapy Sales Volume by Application (2018-2023)
-
Table North China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Figure North China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Table Central China Immuno-oncology Therapy Production Volume by Type (2018-2023)
-
Table Central China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Figure Central China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Table Central China Immuno-oncology Therapy Sales Volume by Application (2018-2023)
-
Table Central China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Table South China Immuno-oncology Therapy Production Volume by Type (2018-2023)
-
Table South China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Figure South China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Table South China Immuno-oncology Therapy Sales Volume by Application (2018-2023)
-
Table South China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Figure South China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Table East China Immuno-oncology Therapy Production Volume by Type (2018-2023)
-
Table East China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Figure East China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Table East China Immuno-oncology Therapy Sales Volume by Application (2018-2023)
-
Table East China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Figure East China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Immuno-oncology Therapy Production Volume by Type (2018-2023)
-
Table Northeast China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Immuno-oncology Therapy Sales Volume by Application (2018-2023)
-
Table Northeast China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Immuno-oncology Therapy Production Volume by Type (2018-2023)
-
Table Southwest China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Immuno-oncology Therapy Sales Volume by Application (2018-2023)
-
Table Southwest China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Immuno-oncology Therapy Production Volume by Type (2018-2023)
-
Table Northwest China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Immuno-oncology Therapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Immuno-oncology Therapy Sales Volume by Application (2018-2023)
-
Table Northwest China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Immuno-oncology Therapy Sales Volume Share by Application (2018-2023)
-
Table Merck Company Profile
-
Table Merck Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Autolus Therapeutics Company Profile
-
Table Autolus Therapeutics Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Takeda Company Profile
-
Table Takeda Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table BioNTech SE Company Profile
-
Table BioNTech SE Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Arcus Biosciences Company Profile
-
Table Arcus Biosciences Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Janssen Biotech Company Profile
-
Table Janssen Biotech Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Allogene Therapeutics Company Profile
-
Table Allogene Therapeutics Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Spectrum Pharmaceuticals Company Profile
-
Table Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table IMAB-I-Mab Biopharma Co, Ltd Company Profile
-
Table IMAB-I-Mab Biopharma Co, Ltd Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Gritstone Oncology Company Profile
-
Table Gritstone Oncology Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Immuno-oncology Therapy Revenue, Price and Gross (2018-2023)
-
